Literature DB >> 16518668

Age and gender related reference values for transthoracic Doppler-echocardiography in the anesthetized CD1 mouse.

Jörg Stypmann1, Markus A Engelen, Constanze Epping, Harold V M van Rijen, Peter Milberg, Christian Bruch, Günter Breithardt, Klaus Tiemann, Lars Eckardt.   

Abstract

OBJECTIVE: Doppler-echocardiography of the mouse has evolved to a commonly used technique in the past years as recent advances in imaging quality have substantially improved spatial and temporal resolution allowing the adaptation of this technique to murine models. Although mouse echocardiography is widely used, there is only little information on reference data for wild-type animals available, particularly in older mice.
METHODS: We therefore established a database with echocardiographic reference-values in a large set of young (8 weeks) and older adult (52 weeks) Swiss type CD1-mice of either sex. We performed a complete Doppler-echocardiographic examination under light Ketamine-Xylazine-anesthesia. LV-mass was calculated and compared with necropsy heart weights to validate the LV-mass calculation.
RESULTS: Doppler-echocardiographic measurements in mice were feasible to assess cardiac morphology and function. Sonomorphological and functional parameters hardly changed between the age of 12 and 52 weeks. Wall thickness, LV-mass and cardiac output were stable with aging. There was a good relative correlation between echocardiographically estimated LV-mass and necropsy heart weight although absolute values differed. There were no significant echocardiographic differences between male and female mice.
CONCLUSIONS: The reference values established in this study can be useful in recording and quantifying pathological changes in murine models of cardiovascular diseases. There is hardly any change of cardiac function between the age of 12 and 52 weeks.

Entities:  

Mesh:

Year:  2006        PMID: 16518668     DOI: 10.1007/s10554-005-9052-9

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  42 in total

Review 1.  Cardiovascular consequences of the aging process.

Authors:  J F Lewis; B J Maron
Journal:  Cardiovasc Clin       Date:  1992

2.  Cardiomyopathy induced by cardiac Gs alpha overexpression.

Authors:  M Iwase; M Uechi; D E Vatner; K Asai; R P Shannon; R K Kudej; T E Wagner; D C Wight; T A Patrick; Y Ishikawa; C J Homcy; S F Vatner
Journal:  Am J Physiol       Date:  1997-01

3.  Comparison of two murine models of familial hypertrophic cardiomyopathy.

Authors:  B K McConnell; D Fatkin; C Semsarian; K A Jones; D Georgakopoulos; C T Maguire; M J Healey; J O Mudd; I P Moskowitz; D A Conner; M Giewat; H Wakimoto; C I Berul; F J Schoen; D A Kass; C E Seidman; J G Seidman
Journal:  Circ Res       Date:  2001-03-02       Impact factor: 17.367

4.  Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice.

Authors:  K Harada; I Komuro; I Shiojima; D Hayashi; S Kudoh; T Mizuno; K Kijima; H Matsubara; T Sugaya; K Murakami; Y Yazaki
Journal:  Circulation       Date:  1998-05-19       Impact factor: 29.690

5.  An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy.

Authors:  D Fatkin; B K McConnell; J O Mudd; C Semsarian; I G Moskowitz; F J Schoen; M Giewat; C E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  Impact of anesthesia on cardiac function during echocardiography in mice.

Authors:  David M Roth; James S Swaney; Nancy D Dalton; Elizabeth A Gilpin; John Ross
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

7.  Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.

Authors:  Y Y Li; Y Q Feng; T Kadokami; C F McTiernan; R Draviam; S C Watkins; A M Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

8.  Cellular and functional defects in a mouse model of heart failure.

Authors:  G Esposito; L F Santana; K Dilly; J D Cruz; L Mao; W J Lederer; H A Rockman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

9.  Cardiovascular indexes in the mouse at rest and with exercise: new tools to study models of cardiac disease.

Authors:  K H Desai; R Sato; E Schauble; G S Barsh; B K Kobilka; D Bernstein
Journal:  Am J Physiol       Date:  1997-02

10.  Cardiac and ocular pathologies in a mouse model of mucopolysaccharidosis type VI.

Authors:  Oliver F Strauch; Jörg Stypmann; Thomas Reinheckel; Elke Martinez; Wilhelm Haverkamp; Christoph Peters
Journal:  Pediatr Res       Date:  2003-08-06       Impact factor: 3.756

View more
  12 in total

1.  Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload.

Authors:  Karl Toischer; Wuqiang Zhu; Mark Hünlich; Belal A Mohamed; Sara Khadjeh; Sean P Reuter; Katrin Schäfer; Deepak Ramanujam; Stefan Engelhardt; Loren J Field; Gerd Hasenfuss
Journal:  J Clin Invest       Date:  2017-10-30       Impact factor: 14.808

2.  Differences in aortic arch geometry, hemodynamics, and plaque patterns between C57BL/6 and 129/SvEv mice.

Authors:  Hui Zhu; Ji Zhang; Jessica Shih; Federico Lopez-Bertoni; John R Hagaman; Nobuyo Maeda; Morton H Friedman
Journal:  J Biomech Eng       Date:  2009-12       Impact factor: 2.097

3.  Non-invasive in vivo measurement of cardiac output in C57BL/6 mice using high frequency transthoracic ultrasound: evaluation of gender and body weight effects.

Authors:  Elisabet Domínguez; Jesús Ruberte; José Ríos; Rosa Novellas; Maria Montserrat Rivera Del Alamo; Marc Navarro; Yvonne Espada
Journal:  Int J Cardiovasc Imaging       Date:  2014-05-23       Impact factor: 2.357

4.  Age- and gender-related changes in ventricular performance in wild-type FVB/N mice as evaluated by conventional and vector velocity echocardiography imaging: a retrospective study.

Authors:  Sheryl E Koch; Kevin J Haworth; Nathan Robbins; Margaret A Smith; Navneet Lather; Ahmad Anjak; Min Jiang; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  Ultrasound Med Biol       Date:  2013-06-19       Impact factor: 2.998

5.  Increase in cardiac myosin heavy-chain (MyHC) alpha protein isoform in hibernating ground squirrels, with echocardiographic visualization of ventricular wall hypertrophy and prolonged contraction.

Authors:  O Lynne Nelson; Bryan C Rourke
Journal:  J Exp Biol       Date:  2013-09-26       Impact factor: 3.312

6.  The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice.

Authors:  Michaela Kuhn; Katharina Völker; Kristine Schwarz; Javier Carbajo-Lozoya; Ulrich Flögel; Christoph Jacoby; Jörg Stypmann; Martin van Eickels; Stepan Gambaryan; Michael Hartmann; Matthias Werner; Thomas Wieland; Jürgen Schrader; Hideo A Baba
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

7.  Effects of injectable anesthetic combinations on left ventricular function and cardiac morphology in Sprague-Dawley rats.

Authors:  Carla F Sabatini; M Lynne O'Sullivan; James E Valcour; William Sears; Ron J Johnson
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-01       Impact factor: 1.232

Review 8.  Sex differences in mechanisms of cardiac excitation-contraction coupling.

Authors:  Randi J Parks; Susan E Howlett
Journal:  Pflugers Arch       Date:  2013-02-17       Impact factor: 3.657

9.  Long-term Intake of Pasta Containing Barley (1-3)Beta-D-Glucan Increases Neovascularization-mediated Cardioprotection through Endothelial Upregulation of Vascular Endothelial Growth Factor and Parkin.

Authors:  Valentina Casieri; Marco Matteucci; Claudia Cavallini; Milena Torti; Michele Torelli; Vincenzo Lionetti
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

10.  Transthoracic echocardiography reference values in juvenile and adult 129/Sv mice.

Authors:  Maurícia Vinhas; Ana Carolina Araújo; Sónia Ribeiro; Luís Brás Rosário; José António Belo
Journal:  Cardiovasc Ultrasound       Date:  2013-05-01       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.